These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38134043)

  • 1. Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN.
    Avenant C; Bick AJ; Skosana SB; Dlamini S; Balakrishna Y; Moliki JM; Singata-Madliki M; Hofmeyr GJ; Smit J; Beksinska M; Beesham I; Seocharan I; Batting J; Chen PL; Storbeck KH; Africander D; Hapgood JP
    PLoS One; 2023; 18(12):e0295959. PubMed ID: 38134043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial.
    Avenant C; Singata-Madliki M; Bick AJ; Africander D; Balakrishna Y; Storbeck KH; Moliki JM; Dlamini S; Skosana S; Smit J; Beksinska M; Beesham I; Seocharan I; Batting J; Hofmeyr GJ; Hapgood JP
    PLoS One; 2024; 19(8):e0307736. PubMed ID: 39178280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial.
    Singata-Madliki M; Smit J; Beksinska M; Balakrishna Y; Avenant C; Beesham I; Seocharan I; Batting J; Hapgood JP; Hofmeyr GJ
    PLoS One; 2024; 19(3):e0295764. PubMed ID: 38530848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.
    Heffron R; Achilles SL; Dorflinger LJ; Hapgood JP; Kiarie J; Polis CB; Steyn PS
    Contraception; 2019 Apr; 99(4):199-204. PubMed ID: 30576636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.
    Dabee S; Tanko RF; Brown BP; Bunjun R; Balle C; Feng C; Konstantinus IN; Jaumdally SZ; Onono M; Nair G; Palanee-Phillips T; Gill K; Baeten JM; Bekker LG; Passmore JS; Heffron R; Jaspan HB; Happel AU
    Front Immunol; 2021; 12():760504. PubMed ID: 34956191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting hormonal contraceptives for women.
    Garza-Flores J; Hall PE; Perez-Palacios G
    J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels.
    Maritz MF; Ray RM; Bick AJ; Tomasicchio M; Woodland JG; Govender Y; Avenant C; Hapgood JP
    PLoS One; 2018; 13(4):e0196043. PubMed ID: 29698514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations.
    Ray RM; Maritz MF; Avenant C; Tomasicchio M; Dlamini S; van der Spuy Z; Hapgood JP
    Sci Rep; 2019 Mar; 9(1):4334. PubMed ID: 30867477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
    Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
    Huijbregts RP; Michel KG; Hel Z
    Contraception; 2014 Aug; 90(2):123-9. PubMed ID: 24674041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
    Fahmy K; Abdel-Razik M; Shaaraway M; al-Kholy G; Saad S; Wagdi A; al-Azzony M
    Contraception; 1991 Oct; 44(4):419-30. PubMed ID: 1836754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-a-month estrogen/progestogen injectables.
    D'arcangues C
    Entre Nous Cph Den; 1991 Dec; (19):15. PubMed ID: 12222332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
    Gray RH; Parker RA; Diethelm P
    Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestin-only injectables offer many advantages.
    Finger WR
    Netw Res Triangle Park N C; 1995 Jun; 15(4):16-20. PubMed ID: 12289828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial.
    Singata-Madliki M; Lawrie TA; Balakrishna Y; d'Hellencourt FC; Hofmeyr GJ
    Reprod Health; 2021 Sep; 18(1):192. PubMed ID: 34587971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
    Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K
    mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.
    Draper BH; Morroni C; Hoffman M; Smit J; Beksinska M; Hapgood J; Van der Merwe L
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD005214. PubMed ID: 16856087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.